Compare Charles River Laboratories Intl. Inc (CRL) vs National Beverage Corp. (FIZZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs National Beverage Corp. — how do they compare? Charles River Laboratories Intl. Inc trades at $301.4 (market cap $14.23B), while National Beverage Corp. trades at $30.61 (market cap $2.89B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 4.9× National Beverage Corp.'s market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, National Beverage Corp. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and National Beverage Corp. for 33 Days on average.
| CRL | FIZZ | |
|---|---|---|
Market Cap | $14.23B | $2.89B |
Volume | 1,176,885 | 553,950 |
Sector | Health | Consumer Staples |
52-Week High | $310.77 | $37.73 |
52-Week Low | $149.93 | $29.20 |
Typical Hold Time | 33 Days | 33 Days |
Enterprise Value | $17.06B | $2.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRL trades at $304.01, up 1.24% on the day, near the consensus price target of $305.50. The stock shows a bullish technical trend with strong analyst support (73% buy ratings) and has beaten EPS estimates for three consecutive quarters. However, fundamentals reveal challenges with negative net income margins and a high P/E ratio of 684.85, while recent news highlights a strategic growth plan targeting 5-7% revenue growth and $300 million in savings by 2030.
The outlook is cautiously optimistic given strong analyst sentiment and recent earnings beats, but high valuation and profitability concerns pose risks. Investment opportunity hinges on successful execution of the new growth strategy to improve margins, while key risks include persistent negative earnings, competitive pressures, and execution missteps in achieving long-term targets.
National Beverage Corp. (FIZZ) trades at $30.52, up 3.11% today, showing mixed signals with a bullish technical outlook but bearish analyst sentiment. The company reported flat revenue of $1.2B in 2025 with net income of $186.82M, while recent quarterly earnings have missed expectations. Technical indicators show support at $30 and resistance at $31, with RSI in neutral territory. Recent news highlights margin pressure from tariffs and a $3.25 special dividend payment.
FIZZ faces headwinds from stalled revenue growth and margin compression, though strong profitability metrics (40.13% ROE) provide some support. Analyst consensus is cautious with 50% sell ratings, while institutional activity shows mixed positioning. The stock's valuation appears reasonable at 16.58 P/E, but investors should monitor earnings recovery and competitive pressures in the beverage sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About National Beverage Corp.
National Beverage Corp is one of the top 10 non-alcoholic beverage companies in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls most of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for big-box retailers, direct-store-delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants). It is controlled by chairman and CEO Nick Caporella, who owns over 73% of the common stock.
Read more on FIZZ →
